75.89
5.89 (8.41%)
| Previous Close | 70.00 |
| Open | 72.50 |
| Volume | 17,725 |
| Avg. Volume (3M) | 41,373 |
| Market Cap | 246,283,616 |
| Price / Sales | 10.75 |
| Price / Book | 10.65 |
| 52 Weeks Range | |
| Earnings Date | 1 May 2026 |
| Profit Margin | -107.77% |
| Operating Margin (TTM) | -879.63% |
| Diluted EPS (TTM) | -4.70 |
| Quarterly Revenue Growth (YOY) | 121.20% |
| Total Debt/Equity (MRQ) | 5.84% |
| Current Ratio (MRQ) | 5.12 |
| Operating Cash Flow (TTM) | -13.89 M |
| Levered Free Cash Flow (TTM) | -9.91 M |
| Return on Assets (TTM) | -26.82% |
| Return on Equity (TTM) | -49.39% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Sol-Gel Technologies Ltd. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.13 |
|
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 70.00% |
| % Held by Institutions | 24.29% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |